Prior to joining Care Capital, Dr. Mandel had a distinguished 39 year career at Merck, retiring as Vice President of External Scientific Affairs in 2003. He co-established the Company’s licensing function, an effort which resulted in the licensure of several entities and the establishment of many collaborations from which marketed products emerged, including Pepcid, Fosamax, and Cozaar. He also developed the University Relations function in which a range of direct funding and other initiatives with academia were expanded. Prior to these responsibilities, Dr. Mandel was Director of Biochemistry.

Dr. Mandel holds a B.S. degree in Pharmacy and a Ph.D. degree in Biochemistry, both from Columbia University. He was Assistant Professor of Biochemistry and Pharmacology at the Pharmacy College before joining Merck. He was the recipient of fellowships and research grants while in academia, and co-authored 44 scientific papers and 7 patents.